Antidiabetic medications for type 2 diabetics with nonalcoholic fatty liver disease: evidence from a network meta-analysis of randomized controlled trials
CH Ng, SY Lin, YH Chin, MH Lee, N Syn, XL Goh… - Endocrine Practice, 2022 - Elsevier
Objective Type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD) are closely
related, and antidiabetic medications have been shown to be potential therapeutics in
NAFLD. Using a network meta-analysis, we sought to examine the effectiveness of
antidiabetic agents for the treatment of NAFLD in patients with type 2 diabetes mellitus.
Methods Medline and Embase were searched for randomized controlled trials relating to the
use of antidiabetic agents, including sodium-glucose transport protein 2 (SGLT2) inhibitors …
related, and antidiabetic medications have been shown to be potential therapeutics in
NAFLD. Using a network meta-analysis, we sought to examine the effectiveness of
antidiabetic agents for the treatment of NAFLD in patients with type 2 diabetes mellitus.
Methods Medline and Embase were searched for randomized controlled trials relating to the
use of antidiabetic agents, including sodium-glucose transport protein 2 (SGLT2) inhibitors …